Form 8-K - Current report:
SEC Accession No. 0001104659-25-068098
Filing Date
2025-07-15
Accepted
2025-07-15 16:15:42
Documents
12
Period of Report
2025-07-09
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2521012d1_8k.htm   iXBRL 8-K 35745
  Complete submission text file 0001104659-25-068098.txt   205134

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA carm-20250709.xsd EX-101.SCH 3017
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE carm-20250709_lab.xml EX-101.LAB 34239
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE carm-20250709_pre.xml EX-101.PRE 22360
14 EXTRACTED XBRL INSTANCE DOCUMENT tm2521012d1_8k_htm.xml XML 3697
Mailing Address 3675 MARKET STREET SUITE 401 PHILADELPHIA PA 19104
Business Address 3675 MARKET STREET SUITE 401 PHILADELPHIA PA 19104 2674916422
Carisma Therapeutics Inc. (Filer) CIK: 0001485003 (see all company filings)

EIN.: 262025616 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36296 | Film No.: 251124963
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)